DrugMonitor™ Anti-Lerdelimumab Antibody (VS-1224-YC656)
CAT#: VS-1224-YC656
Lerdelimumab is a human monoclonal antibody and immunosuppressant targeting TGF beta 2, with potential for treating fibrosis, cataract, retinopathy, and connective tissue disease. The DrugMonitor™ Anti-Lerdelimumab Antibody (VS-1224-YC656) is an anti-drug antibody (ADA) against Lerdelimumab. This drug-based antibody is raised in mice immunized with the Lerdelimumab. The anti-Lerdelimumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Lerdelimumab in samples.
Specifications
- Host Animal
- Mouse
- Specificity
- Lerdelimumab
- Target
- Lerdelimumab
- Immunogen
- Lerdelimumab
- Type
- Mouse IgG
- Species Reactivity
- Human
- Purity
- >95%
- Purification
- Protein G
- Applications
- ELISA, PK/PD, ADA control
- Format
- Liquid
- Concentration
- Batch-dependent
- Buffer
- PBS, pH 7.4
- Preservative
- No preservatives
- Storage
- Store at 4°C for 1-2 weeks and at -20°C for 1 year. Avoid repeated freezing and thawing.
- Generic name
- Lerdelimumab
- Related Disease
- fibrosis, cataract, retinopathy, and connective tissue disease
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for VS-1224-YC656. Click the button above to contact us or submit your feedback about this product.
Effective Fibrosis Research Reagent
We are investigating TGF beta 2 inhibitors for fibrosis treatment, and this antibody was essential. It specifically targets Lerdelimumab, allowing us to measure drug levels accurately in our ELISA assays and assess its potential in connective tissue disease models.
Good Standard For Immunogenicity Testing
Using this mouse antibody as a reference standard in our ADA assays provided consistent results. It helped us monitor the immunogenic response to the drug in our samples, which is a critical part of evaluating the therapeutic efficacy of this monoclonal antibody.
Q&As
-
What does Lerdelimumab target and what are its potential uses?
A: Lerdelimumab is a human monoclonal antibody and immunosuppressant that targets TGF beta 2. It has potential applications in treating fibrosis, cataract, retinopathy, and connective tissue disease. Our antibody is designed to monitor this specific drug.
-
Can this antibody be used as a reference standard?
A: Yes, the DrugMonitor™ Anti-Lerdelimumab Antibody serves as an excellent reference standard in anti-drug antibody (ADA) assays. It is also suitable for ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses for drug monitoring purposes.
View the frequently asked questions answered by Creative Biolabs Support.
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
See other products for "Lerdelimumab"
Afuco™ Anti-TGFB2 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-100)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to TGF beta 2. It is a human monoclonal antibody and an immunosuppressive drug developed to reduce scarring after glaucoma drainage surgery.
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, IP, FC, FuncS, Neut, IF, IHC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: Block, Cyt, FuncS, Inhib
Application: WB, IHC, FC, Cyt, ELISA
Application: WB, ELISA, FuncS
Application: ELISA, IP, WB, IHC, IF, FuncS
Application: FuncS, Inhib, IP, ELISA
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
